To investigate whether TIM‐4 interference in KCs can reverse CCL4‐induced liver fibrosis, we administered TIM‐4 mAb (0.35 mg/mouse, once per week, for six weeks, red fluorescence labelled) via caudal vein injection to block the function of TIM‐4 in KCs. This evidence concerns the gene TBCE and Hepatic fibrosis.